Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares (CANF) is a publicly traded Healthcare sector company. As of July 2, 2026, CANF trades at $3.79 with a market cap of $6.36M and a P/E ratio of 0.00. CANF moved -18.99% today. Year to date, CANF is +5.23%; over the trailing twelve months it is -77.74%. Its 52-week range spans $2.56 to $47.00. Analyst consensus is buy with an average price target of $6.00. Rallies surfaces CANF's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for CANF combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $3.79 |
| Market Cap | $6.36M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $47.00 |
| 52-Week Low | $2.56 |
| Volume | 895.03K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
2 analysts cover CANF: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $6.00.